Search

everythinglearnresearchcommunity

for

Search:↓

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Popliteal Artery Entrapment Syndrome (PAES) is a rare but possible cause of leg pain during walking, even in untrained women.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

The P&P Hairline Laser is a new, hands-free device that improves hairline symmetry in hair restoration surgery and can create a symmetrical hairline in less than a minute.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Deep Brain Stimulation helps manage Parkinson's symptoms when medication isn't enough.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

The enzyme PA-PLA1α is important for proper hair follicle development.

PDGF-D boosts stem cell growth and movement, enhancing hair regeneration.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Targeting LPA could help treat skin disorders.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Home-use treatment for severe alopecia areata is as effective as office-use but costs half as much.

Researchers developed a method to grow hair follicle cells for transplantation using a special chip.